Home / Companies / Shenzhen Mindray Bio-Medical Electronics Co., Ltd. / 20 May 2025
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.: meeting of 20 May 2025
Votes reported on Form N-PX, item by item
95 Form N-PX filers reported votes at the Shenzhen Mindray Bio-Medical Electronics Co., Ltd. meeting of 20 May 2025. Their records fall into 5 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
179 vote records from 95 filers. 2 of the 95 filers that marked the item either way voted against management.
CAPITAL STRUCTUREIssuer
CAPITAL STRUCTURE: management items
Management items in this category are shown together; filers word and number them differently.
514 vote records from 94 filers. 0 of the 94 filers that marked the item either way voted against management.
COMPENSATIONIssuer
COMPENSATION: management items
Management items in this category are shown together; filers word and number them differently.
167 vote records from 84 filers. 0 of the 84 filers that marked the item either way voted against management.
CORPORATE GOVERNANCEIssuer
CORPORATE GOVERNANCE: management items
Management items in this category are shown together; filers word and number them differently.
2,058 vote records from 95 filers. 0 of the 95 filers that marked the item either way voted against management.
OTHERIssuer
OTHER: management items
Management items in this category are shown together; filers word and number them differently.
125 vote records from 15 filers. 0 of the 15 filers that marked the item either way voted against management.
How the largest families voted
| Family | 1. Auditor |
|---|---|
| Vanguard | For |
| BlackRock and iShares | For |
| Fidelity | For |
| Dimensional | For |
| State Street and SPDR | For |
| Franklin Templeton | For |
| Equitable | Abstain or withhold * |
| Charles Schwab | For |
| Nuveen and TIAA | For |
| John Hancock and Manulife | For |
| Morgan Stanley, Eaton Vance and Calvert | For |
| J.P. Morgan | For |
| Goldman Sachs | For |
| WisdomTree | For |
| Jackson National funds | For |
| Northern Trust and FlexShares | For |
| SEI | For |
| Lincoln Financial | For |
| Voya | For |
| Russell Investments | For |
| Brighthouse Funds | For |
| Columbia Threadneedle | For |
| BNY Mellon | Against * |
| Pacific Life funds | For |
| Transamerica | For |
| Hartford Funds | For |
| DWS | For |
| PIMCO | For |
| Allspring | For |
| VanEck | For |
| Macquarie and Delaware Funds | For |
| Neuberger Berman | For |
| American Beacon | For |
| Artisan Partners | For |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Shenzhen Mindray Bio-Medical Electronics Co., Ltd. meeting?
95 Form N-PX filers reported votes at the meeting of 20 May 2025. The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Shenzhen Mindray Bio-Medical Electronics Co., Ltd. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Shenzhen Mindray Bio-Medical Electronics Co., Ltd. with a meeting date within three days of 20 May 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.